CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...